Behavioral and Lifestyle Barriers to Success Semaglutide reduces hunger and increases fullness signals, but it does not eliminate food choice, portion discipline, or stress-driven eating patterns entirely

Drug Class: GLP-1 Receptor Agonist Incretin mimetic antidiabetic agent Uses / Indications: Type 2 Diabetes Mellitus Chronic Weight Management (Obesity) Cardiovascular risk reduction in patients with T2DM Glycemic control with lifestyle modification Mechanism of Action: Activates GLP-1 receptors Increases glucose-dependent insulin secretion Suppresses glucagon release Delays gastric emptying Promotes satiety and weight loss Dose: Subcutaneous: Start 0.25 mg once weekly for 4 weeks Increase to 0.5 mg once weekly May increase gradually up to 2.4 mg weekly depending on indication Oral: 3 mg once daily initially Take on an empty stomach with a small amount of water Adverse Effects: Nausea Vomiting Diarrhea Decreased appetite Pancreatitis (rare) Gallbladder disease Contraindications: Personal or family history of Medullary Thyroid Carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Hypersensitivity to semaglutide Severe gastrointestinal disease (use with caution) Drug Interactions: Insulin / Sulfonylureas risk of hypoglycemia Delayed gastric emptying altered absorption of oral drugs Warfarin monitor INR carefully Alcohol GI adverse effects Brand Names: Ozempic Wegovy Rybelsus Clinical Pearl: Semaglutide significantly improves HbA1c levels, promotes substantial weight loss, and reduces cardiovascular risk, making it a powerful therapy in modern Type 2 Diabetes and obesity management

Theyre also great for helping even skin tone, repair sun damage, or reduce the appearance of wrinkles
Food and Drug Administration (FDA) requires that all drug labels include known side effects
If your state is not on the list, you will need to use a different compounding pharmacy